Epidemiological Study in Subjects With Vulvovaginal Candidiases

Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)

NCT04029116 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis

NCT02679456 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303)

NCT03734991 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis

NCT03987620 ·Status: COMPLETED ·Phase: PHASE3

Prospective Population Study on Candidemia in Spain

NCT01236261 ·Status: COMPLETED

Vulvovaginal Candidiasis in Canadian Females

NCT04930107 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

Study of Innate Host Immune Response to C. Glabrata Clinical Isolates Resistant to Echinocandins: Impact on the Management of Candidemia in High-risk Patients

NCT03652194 ·Status: UNKNOWN

Efficacy of the Vacucis Candida® Autovaccine

NCT05289375 ·Status: NOT_YET_RECRUITING ·Phase: NA

An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia

NCT03604705 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Recurrent Vulvovaginal Candidiasis

NCT05074602 ·Status: UNKNOWN ·Phase: PHASE3

This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis

NCT00548262 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis.

NCT05031481 ·Status: WITHDRAWN ·Phase: PHASE2

Safety and Clinical and Microbiological Efficacy of the Combination of Fluconazole and Secnidazole for the Treatment of Symptomatic Vaginal Discharge

NCT02111629 ·Status: COMPLETED ·Phase: PHASE3

A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC)

NCT04734405 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization

NCT02888197 ·Status: COMPLETED

Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study

NCT00689338 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole

NCT05178862 ·Status: TERMINATED ·Phase: PHASE3

Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women

NCT01915251 ·Status: TERMINATED

A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Acute Vulvovaginal Candidiasis

NCT04956419 ·Status: UNKNOWN ·Phase: PHASE3

Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis

NCT02244606 ·Status: COMPLETED ·Phase: PHASE2

Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection

NCT01137292 ·Status: COMPLETED

ProF-001_Phase IIa

NCT03115073 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

NCT05399641 ·Status: COMPLETED ·Phase: PHASE3

A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

NCT03561701 ·Status: COMPLETED ·Phase: PHASE3

A Study of Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

NCT03562156 ·Status: COMPLETED ·Phase: PHASE3